Centre for Evaluation of Vaccination (CEV)
The executive VHPB secretariat benefits from being seated at the Center for the Evaluation of Vaccination (CEV) of the University of Antwerpen, where it has the infrastructure and administrative services of the University at its disposal.
VHPB is supported by unrestricted grants from the vaccine industry (GlaxoSmithKline Biologicals, Sanofi Pasteur MSD, Sanofi Pasteur and in the past als by Merck), several universities in Europe and other institutions.
Recently the VHPB received unrestricted< support on a meeting base from Bristol-Myers Squibb (BMS), Gilead and Janssen.
In the past, the VHPB also received support from the Global Alliance for Vaccines and Immunisation Fund and the Children's Vaccine Program at PATH for its activities in CEE and NIS.
For the VHPB and its advisors strict operational and scientific independence is essential. VHPB advisers and invited experts get only travel and subsistence reimbursed according to the University Rules, no honorary or other forms of remuneration are provided.
The VHPB does accept unrestricted grants from companies to support their activities including web development but maintains all editorial control over the content of the site. Editorial control of the site rests entirely with the secretariat of the VHPB.